Partner With Us: Digital Biomarkers & AI for Pandemic Preparedness – Horizon Europe 2025

From Idea to Approval: How Chelonia Builds Horizon Europe Projects That Deliver Impact

Designing a successful Horizon Europe project is more than a race against deadlines. It’s a strategic journey—from scouting the right opportunity to building the right consortium, submitting a compelling proposal, and guiding it to approval.

At Chelonia, we don’t just “participate” in European projects—we design and drive them, ensuring that each initiative serves both scientific progress and the real-world needs of our partners.

🚀 Case Study: From Concept to Approval in Under 6 Months

Last year, Chelonia supported a biotech client in building a Horizon Europe proposal focused on AI for clinical validation. Within 3 weeks, we had refined the strategic concept and matched it to a suitable call. In just 2 months, we coordinated a European consortium of 10 partners—research centers, tech companies, and hospitals. Together, we drafted a high-impact proposal with a clear innovation pathway, stakeholder engagement strategy, and a robust exploitation plan. The proposal was submitted by the official deadline and received approval within 6 months, securing over 7 million EUR in co-funding. Most importantly, it positioned our client as a key player in a high-priority EU innovation area. This is the Chelonia method: structured, fast, and always focused on creating value.

🧭 Where We Are Now: Calls with Mid-September Deadlines

Right now, Chelonia is leading the design of new proposals in response to upcoming Horizon Europe calls with submission deadlines in mid-September 2025. We're focusing on two critical topics that lie at the heart of Europe's scientific and societal priorities:

🔬 1. Digital Biomarkers

We’re working with partners to identify, validate, and implement digital biomarkers using real-world data from wearables, smartphones, and digital platforms. This includes projects at the intersection of AI, behavioral science, and personalized medicine.

🦠 2. Pandemic Preparedness Leveraging AI

Building on lessons from COVID-19, we are designing proposals that apply AI to early detection, surveillance, and rapid response strategies—bridging data science, virology, clinical infrastructure, and public health.

🤝 Join Us: Let’s Build Together

Are you working in one of these areas—digital biomarkers or pandemic preparedness using AI?

Do you have:

• A research asset or validated methodology?

• Access to real-world data or clinical insight?

• Technology that could scale through EU collaboration?

If so, we’d love to hear from you.

📩 Send us a DM to set up a quick video call. We’re currently aligning final partners for our September submissions—and this may be the perfect moment to join forces.

Let’s turn today’s insights into tomorrow’s innovation.

With Chelonia, you’re not just part of the consortium. You’re part of the strategy.